Evidence map›Paper›PMID 30366594›Full record

ArticleThe American journal of pathology2018

Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury: Evidence for Smoothened-Mediated Activation of NF-κB/Epidermal Growth Factor Receptor/Akt in Hepatocytes that Counteract Fas-Induced Apoptosis.

Ying Wang, Weina Chen, Chang Han, Jinqiang Zhang, Kyoungsub Song, Hyunjoo Kwon, Srikanta Dash, Lu Yao, Tong Wu

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. "Hedgehog pathway": a potential target of itraconazole in the treatment of cancer.Journal of cancer research and clinical oncology · 2020
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Ying WangDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Department of Gastroenterology and Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Weina ChenDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Chang HanDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Jinqiang ZhangDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Kyoungsub SongDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Hyunjoo KwonDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Srikanta DashDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Lu YaoDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Tong WuDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana. Electronic address: twu@tulane.edu.
Tulane University · US

Funding

cPLA2, COX-2 and PPAR-gamma in CholangiocarcinomaR01CA102325 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WU, TONG · 2005 to 2020
$3.8M
Prostaglandin Signaling Pathway in Liver CancerR01CA106280 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WU, TONG · 2005 to 2013
$2.1M
NCI NIH HHS R01 CA102325NCI NIH HHS R01 CA106280
6 · The paper itself

Abstract

Although hedgehog (Hh) signaling pathway is inactive in adult healthy liver, it becomes activated during acute and chronic liver injury and, thus, modulates the reparative process and disease progression. We developed a novel mouse model with liver-specific knockout of Smoothened (Smo LKO), and animals were subjected to Fas-induced liver injury in vivo. Results showed that Smo deletion in hepatocytes enhances Fas-induced liver injury. Activation of Hh signaling in hepatocytes in the setting of Fas-induced injury was indicated by the fact that Jo2 treatment enhanced hepatic expression of Ptch1, Smo, and its downstream target Gli1 in control but not Smo LKO mice. Primary hepatocytes from control mice showed increased Hh signaling activation in response to Jo2 treatment in vitro. On the other hand, the Smo KO hepatocytes were devoid of Hh activation and were more susceptible to Jo2-induced apoptosis. The levels of NF-κB and related signaling molecules, including epidermal growth factor receptor and Akt, were lower in Smo KO livers/hepatocytes than in control livers/hepatocytes. Accordingly, hydrodynamic gene delivery of active NK-κB prevented Jo2-induced liver injury in the Smo LKO mice. Our findings provide important evidence that adult hepatocytes become responsive to Hh signaling through up-regulation of Smo in the setting of Fas-induced liver injury and that such alteration leads to activation of NF-κB/epidermal growth factor receptor/Akt, which counteracts Fas-induced hepatocyte apoptosis.

Indexed as

ApoptosisAcute Lung InjuryAnimalsCells, CulturedErbB Receptorsfas ReceptorHedgehog ProteinsHepatocytesLiverMaleMiceMice, KnockoutNF-kappa BProto-Oncogene Proteins c-aktSmoothened ReceptorEGFR protein, mouseErbB ReceptorsFas protein, mousefas ReceptorHedgehog ProteinsNF-kappa BProto-Oncogene Proteins c-aktSmoothened ReceptorSmo protein, mouse

Identifiers

PMID30366594
PMCPMC6207910
OpenAlexW2896226433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.